Provocative Questions in Cancer Research: National Cancer Institute Science Writers’ Seminar

What:        Please join us for a science writers' seminar to discuss various aspects of one of NCI’s signature efforts -- the Provocative Questions project. Discussion will focus on the scientific research that surrounds some of these questions. The seminar will allow ample time for Q&A and interaction during the talks.

Who:        Experts from NCI include:

                        The Provocative Questions Program: An overview
                        Ed Harlow, Ph.D., special advisor to the NCI Director

                        How can drugs, such as aspirin or metformin, which are used for other medical
                        indications, protect against cancer?
                        Asad Umar, Ph.D., chief, Gastrointestinal & Other Cancers Research Group, NCI/
                        Brandy Heckman, Ph.D, program director, Breast and Gynecologic Cancer Research
                        Group, NCI

                        How do we improve tumor detection and characterization with diagnostic
                        imaging?
                        Lalitha Shankar, M.D., Ph.D., branch chief, Clinical Trials Branch, Cancer Imaging
                        Program, NCI

                        Can we develop preclinical models that better predict the efficacy of new
                        drugs and drug combinations?
                        Glen Merlino, Ph.D., chief, Laboratory of Cancer Biology and Genetics, NCI

When:        Monday, December 10, 2012:  2:00- 4:00 p.m. (EST)
                   Registration is at 1:45 p.m. Talks by experts begin at 2:00 p.m.

Where:     National Institutes of Health: Building 31, Room 11A01

How:        For reporters, please register for the seminar by contacting the NCI Press Office at (301)
                496-6641 or ncipressofficers@mail.nih.gov. Space is limited. If you are unable to attend in
                person, you may participate online: https://webmeeting.nih.gov/sws_pq/.